Hot Pursuit     04-Jan-24
Biocon Ltd spurts 0.58%, gains for fifth straight session
Biocon Ltd is quoting at Rs 284, up 0.58% on the day as on 12:44 IST on the NSE. The stock is up 9.15% in last one year as compared to a 20.43% gain in NIFTY and a 36.97% gain in the Nifty Pharma.

Biocon Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 284, up 0.58% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.7% on the day, quoting at 21667.15. The Sensex is at 71884.8, up 0.74%. Biocon Ltd has added around 16.82% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has added around 7.63% in last one month and is currently quoting at 17379.8, up 0.51% on the day. The volume in the stock stood at 72.34 lakh shares today, compared to the daily average of 55.77 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 285.6, up 0.37% on the day. Biocon Ltd is up 9.15% in last one year as compared to a 20.43% gain in NIFTY and a 36.97% gain in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending September 23.

Previous News
  Biocon arm gets USFDA nod for chronic heart failure drug
 ( Hot Pursuit - 02-Sep-24   08:59 )
  Biocon signs licensing and supply agreement with Tabuk Pharmaceutical
 ( Corporate News - 26-Sep-24   19:00 )
  Biocon inks deal with Tabuk Pharma to commercialize GLP -1 products in Middle East
 ( Hot Pursuit - 27-Sep-24   11:03 )
  Biocon Ltd spurts 4.01%, rises for fifth straight session
 ( Hot Pursuit - 26-Apr-24   13:00 )
  Biocon Ltd spurts 1.83%, gains for third straight session
 ( Hot Pursuit - 22-Mar-24   13:05 )
  Biocon Ltd up for third consecutive session
 ( Hot Pursuit - 01-Dec-23   13:05 )
  ICICI Bank board to mull fund raising proposal
 ( Hot Pursuit - 20-Apr-24   14:40 )
  Biocon rallies after recording PAT of Rs 126 cr in Q2 FY24
 ( Hot Pursuit - 12-Nov-23   18:17 )
  Biocon gains after receiving MHRA UK approval for Liraglutide injection
 ( Hot Pursuit - 01-Apr-24   10:34 )
  Board of Biocon to consider NCD issuance and investment in Biocon Biologics
 ( Corporate News - 24-Apr-23   09:50 )
  Biocon's Hyderabad facility gets 3 USFDA observations
 ( Hot Pursuit - 22-Jul-22   08:34 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top